JD Supra May 27, 2020
McGuireWoods LLP

The 2019 novel coronavirus (COVID-19) pandemic continues to have a significant effect on American lives and businesses. The healthcare industry is no exception, and private equity funds and other strategic buyers that invest in the healthcare industry should be aware of key COVID-19-related trends and considerations regarding the acquisition or sale of healthcare businesses. McGuireWoods lawyers are assisting private equity clients in a significant number of buy-side and sell-side transactions in the healthcare industry and are standing by to advise on COVID-19 key trends and considerations in acquisitions, including the following:

  1. Diligence Considerations. Legal diligence has changed rapidly to address the unique issues healthcare companies face as a result of COVID-19. Understanding any governmental relief that a company has...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Technology, Trends
Dear venture capitalists: You're blowing it
Funding Flows to Value-Based Care, Defib Tech, Analytics, and More | StartUp Health Insights: Week of Apr 23, 2024
Evidence On Private Equity Suggests That Containing Costs And Improving Outcomes May Go Hand-In-Hand
PE Firm Avesi Partners Acquires Addiction Provider First Steps Recovery
Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn't fully recovered just yet

Share This Article